Business, energy, technology, markets and global industry news from Business News Today

TactiFlex Duo

Features & Analysis

FDA approved Abbott’s dual-energy AFib catheter. Can procedural flexibility beat single-energy simplicity?

Abbott Laboratories has received FDA approval for TactiFlex Duo, a focal ablation catheter capable of delivering both pulsed-field and radiofrequency energy. The system enters a rapidly expanding pulsed-field ablation market with a different proposition: instead of replacing thermal ablation entirely, it lets electrophysiologists choose between energy types during the same procedure.

Read More
Medical Devices & Diagnostics

Abbott wins FDA approval for dual-energy TactiFlex Duo. Does AFib ablation need two tools in one?

Abbott’s TactiFlex Duo combines pulsed field ablation and radiofrequency energy in one contact-force catheter, giving electrophysiologists a way to move between tissue-selective PFA and conventional thermal ablation without changing platforms during an AFib procedure.

Read More
Medical Devices & Diagnostics

Abbott TactiFlex Duo keeps 92.6% of AFib patients free of documented recurrence in standard monitoring

Abbott’s investigational TactiFlex Duo dual-energy ablation catheter delivered favorable 12-month results in the FlexPulse Global IDE study, supporting the company’s effort to secure U.S. FDA approval after receiving CE Mark in Europe.

Read More